ANA 2020: Studies Support Safety of Calcitonin Gene-Related Peptide Inhibitors for Migraine Treatment
The industry-sponsored studies provide reassuring results about cardiovascular risk
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.